dipeptidyl peptidase-4 inhibitorsglucagon-like peptide-1 (GLP-1) agonistssodium-glucose co-transporter-2 (SGLT-2) inhibitorsthiazolidinedionesTZDshypoglycaemiadiabetes treatmentdiabeteslow blood sugar (BS)
… agonists, sodium-glucose co-transporter-2 (SGLT-2) inhibitors, dipeptidyl peptidase-4 inhibitors and thiazolidinediones (TZDs) have minimal risk of hypoglycaemi…